In this issue of Molecular Cell, Gent et al. (2010) describe the participation of two siRNA populations, generated by two different RNA-directed RNA polymerases, in a pathway to silence expression of endogenous genes in Caenorhabditis elegans.
Small regulatory RNAs mediate transcriptional and posttranscriptional gene silencing in eukaryotes. In recent years, numerous classes of small RNAs have been implicated in transposon silencing, viral defense, developmental gene regulation, and other processes (see Carthew and Sontheimer, 2009; Siomi and Siomi, 2009) . The core components of RNAmediated silencing mechanisms are (1) a small RNA working in conjunction with (2) an Argonaute protein to target specific nucleic acid sequences. One class of small RNAs, called small interfering RNAs (siRNAs), was first identified for its role in exogenous RNA interference (RNAi), a form of gene silencing triggered by introduction of foreign doublestranded RNA (dsRNA) (Fire et al., 1998) ( Figure 1A ). Later, endogenous siRNAs were identified and linked to endogenous mechanisms of gene silencing.
It has been a challenge to understand the physiological importance of different classes of endogenous siRNAs. They may be produced by endonuclease cleavage of a longer dsRNA and/or by activity of an RNA-directed RNA polymerase (RdRP) on single-stranded RNA template. Different siRNAs may have different physical features (length, 5 0 end structures) based on how they were generated. For example, siRNA produced via endonuclease cleavage has a 5 0 monophosphate, whereas endonucleaseindependent siRNA has a 5 0 triphosphate. Also puzzling has been the functional relationships among different siRNA pathways. For example, extensive genetic analysis of the RNAi response in C. elegans identified two classes of mutants: (1) RNAi-defective mutants (rde) are relatively insensitive to exogenous dsRNA (presumably because a component of the core RNAi machinery is absent), and (2) enhanced RNAi (eri) mutants are hyperresponsive to exogenous dsRNA. Accumulation of (at least some) endogenous siRNAs requires both proteins that function in exogenous RNAi (e.g., Dicer endonuclease) and ERI proteins (e.g., the RdRP called RRF-3) (Lee et al., 2006; Duchaine et al., 2006; Yigit et al., 2006) . Hence, it was proposed that endogenous and exogenous RNA silencing pathways share core components; when RRF-3 or another specialized component of the endogenous pathway is disabled, core RNAi components are available to engage more fully in the exogenous RNAi pathway, thus leading to an enhanced RNAi response. Now, Gent et al. (2010) describe a novel mechanism whereby the coordinated activity of two different RdRPs silences gene expression in C. elegans. The authors employed genetic, deep sequencing, and bioinformatic approaches to define populations of siRNAs whose biogenesis depends on the activity of RRF-3 and other ERI factors. By comparing siRNAs isolated from wild-type, rrf-3, and germline-deficient mutants, they identified a large set of RRF-3-dependent siRNAs present in the germline and a rare set present in the soma. The authors chose to focus on somatic RRF-3 function and in particular on production of the most abundant RRF-3-dependent siRNAs, which are generated from a set of 23 ''exemplary'' mRNA templates. These siRNAs are also reduced in animals that are mutant for other eri genes and components of the Dicer complex. A subset of siRNAs targeting these 23 mRNAs was also reduced in animals that lack RRF-1, an RdRP known to function in somatic RNAi.
To determine whether RRF-3-dependent siRNAs promote gene silencing in the soma, as predicted, the authors constructed and characterized mRNA sequencing libraries from several mutants. Putative mRNA targets were indeed elevated in rrf-3 and other eri and Dicer complex mutants as well as in mutants lacking RRF-1 and ERGO-1, an Argonaute protein implicated in ERI pathway function. Hence, all of these factors function to silence a common set of somatic genes.
Bioinformatic analysis of the siRNA sequence data revealed an intriguing pattern: RRF-3 and RRF-1 were responsible for synthesis of two distinct siRNA populations, the 26G and 22G RNAs, respectively. rrf-3 mutants lacked essentially all 26G siRNAs and a subset of 22G RNAs. rrf-1 mutants lacked the same subset of 22G RNAs but had a normal 26G RNA population. 26G and 22G siRNA populations have distinct structural features, consistent with their being produced via different mechanisms. 26G RNAs are 26 nt in length and contain a 5 0 monophosphate consistent with endonuclease cleavage. They are relatively rare among the total endogenous siRNA pool in wild-type somatic tissues. The much more abundant 22G RNAs are 22 nt in length and contain a 5 0 triphosphate group, suggesting they are direct RdRP products and have not undergone endonuclease cleavage. Both populations are predominantly antisense to mRNA sequences, consistent with synthesis from mRNA templates, and their sequences begin at a guanine residue corresponding to a common cysteine in the template.
The authors propose a two-step model wherein RRF-3 and RRF-1 sequentially produce 26G and 22G RNAs to target a set of mRNAs for degradation (Figure 1B) . First, RRF-3/RdRP generates dsRNA from mRNA templates, which is cleaved by Dicer to form 26G siRNAs. The antisense siRNA strand associates with ERGO-1 and may target the same pool of mRNAs for degradation. Second, for some of these RRF-3 targets, RRF-1/ RdRP utilizes the cleaved mRNA species as template, producing 22G siRNAs. These secondary siRNAs participate in a secondary round of RNA silencing that is important for effectively silencing the target gene. Evidence suggests NRDE-3/Argonaute participates at this step.
This model provides an explanation for the enhanced RNAi phenotype of rrf-3 mutants. When RRF-3 is inactive, 26G RNA siRNAs are not produced, freeing RRF-1 to participate in exogenous RNAi. It is worth noting that the authors also detected many mRNA templates for which 26G and 22G RNA production was uncoupled, i.e., RRF-3 produced 26G RNAs from these mRNA templates, but this activity was not required for production of the corresponding 22G RNAs. In these cases, an RRF-3-independent mechanism for 22G RNA production must exist.
The data raise many intriguing mechanistic and functional questions. Do mRNAs contain a signal sequence to attract specific RdRP(s)? What mechanism links RRF-1 activity to RRF-3-targeted mRNAs? Does silencing occur solely at the level of the message or also at the chromatin level? Given that rrf-3 and other eri mutants have relatively subtle somatic phenotypes, what is the physiological/developmental importance of somatic gene silencing via the ERI pathway? In contrast to the soma, eri mutants have striking defects in germline development, particularly in spermatogenesis (Gent et al., 2009; Pavelec et al., 2009; and references therein) . This is not surprising, given that most 26G RNAs are in fact produced in the germline, as reported by Gent et al. (2010) and another recent study by Han et al. (2009) . It seems likely that a two-step RdRP mechanism is active in the germline, perhaps utilizing EGO-1, an RdRP active in germline RNAi, in the second step. Indeed, the implications of this work extend beyond C. elegans to the many organisms that contain multiple RdRPs and hence may utilize similar ) siRNAs that associate with Argonaute protein (AGO) to produce an RNA-induced silencing complex (RISC). RISC is targeted to and cleaves mRNA that is complementary in sequence to the antisense siRNA strand. The silencing response is amplified in organisms containing RdRP, which generates antisense RNA from targeted mRNA templates. Secondary (2 ) siRNAs recruit additional RISC to (intact) target mRNAs, thereby amplifying the RNAi response. C. elegans 2 siRNAs contain a 5 0 triphosphate; in other species, 2 siRNAs may be products of Dicer activity and consequently contain 5 0 monophosphate. (B) RRF-3 utilizes specific mRNA templates to generate dsRNA, which is cleaved by Dicer to generate 26G RNAs. ERGO-1 associates with these 26G RNAs to form RISC, which presumably cleaves mRNA targets. In a secondary phase, RRF-1 produces 22G RNAs from the same mRNA species. These 22G RNAs associate with NRDE-3 (and perhaps other Argonautes), forming secondary RISC complexes that further target mRNA for silencing.
multistep RdRP mechanisms to regulate developmental gene expression.
